Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (PHIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHIO · as of Jun 9, 2026
Key Statistics
Explore Phio Pharmaceuticals Corp. Data
phio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
phio competitorsPHIO
ACXP
APRE
APVO
BCDA
CELZStock Performance
Full HistoryAbout Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. is a U.S.-based company dedicated to creating immune-system-focused cancer treatments. Their proprietary INTASYL therapeutic platform aims to influence both tumor and immune…
what is phio pharmaceuticals corp. · phio stock overview · phio pharmaceuticals corp. company profile · who is phio pharmaceuticals corp. ceo · phio NASDAQ · phio pharmaceuticals corp. headquarters · phio pharmaceuticals corp. business segments
About Stock Overview & Key Data
Phio Pharmaceuticals Corp. (PHIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 10, 2012. As of the latest trading session, PHIO stock price is $1.09, with a market capitalization of $12.7M. The stock has returned -60.93% over the past 12 months and +3.81% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Phio Pharmaceuticals Corp. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Phio Pharmaceuticals Corp. reported revenue of — and net income of -$8.7M. For detailed data — including Phio Pharmaceuticals Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Phio Pharmaceuticals Corp. (PHIO) stock price is $1.09. The stock is traded on NASDAQ under the ticker symbol PHIO. The 52-week range is $0.81 – $4.19.